Ying Wu

Ying Wu is an accomplished professional in the biopharmaceutical industry with extensive experience in technical operations, CMC program management, and process development. Ying Wu's career spans multiple esteemed organizations, including a significant role as Director, CMC at AbbVie since December 2020, where responsibilities include regulatory submission and product lifecycle management. Previous positions include Associate Director, CMC Program Management at AbbVie, Director of a Purification Manufacturing Support Team at Abbott, and roles at US Genomics and MilliporeSigma. Ying Wu holds a Ph.D. in Molecular Biology from the Institute of Biophysics, Chinese Academy of Sciences.